Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Škrha

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Endocrinology, Diabetes & Metabolism|March 23, 2025
The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose SensorsVendula Navrátilová, Eliška Zadáková, Jan Šoupal, et al.
Diabetes Care|May 16, 2020
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 EraAntonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Cardiovascular Diabetology|July 22, 2020
Issues for the management of people with diabetes and COVID-19 in ICUAntonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Casopis Lekaru Ceskych|February 23, 2016
[Early detection of sporadic pancreatic cancer]Přemysl Frič, Aleksi Šedo, Jan Škrha, et al.
Nutrition & Diabetes|April 27, 2018
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentationAnna Cinkajzlová, Miloš Mráz, Zdeňka Lacinová, et al.
Annals of Medicine|July 2, 2026
Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal functionBarbora Agatha Halouzková, Michaela Jelínková, Jan Miroslav Hartinger, et al.
European Journal of Gastroenterology & Hepatology|October 22, 2016
Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkersPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Infectious Disease Reports|February 23, 2024
A Simple Risk Formula for the Prediction of COVID-19 Hospital MortalityJiří Plášek, Jozef Dodulík, Petr Gai, et al.
Cardiovascular Diabetology|October 24, 2020
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetesGuntram Schernthaner, Naim Shehadeh, Alexander S Ametov, et al.
European Journal of Internal Medicine|November 9, 2025
Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM's Diabesity Day Survey 2024Ann-Kristin Porth, Anete Palma, Burcu Sallarel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Endocrinology, Diabetes & Metabolism|March 23, 2025
The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose SensorsVendula Navrátilová, Eliška Zadáková, Jan Šoupal, et al.
Diabetes Care|May 16, 2020
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 EraAntonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Cardiovascular Diabetology|July 22, 2020
Issues for the management of people with diabetes and COVID-19 in ICUAntonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Casopis Lekaru Ceskych|February 23, 2016
[Early detection of sporadic pancreatic cancer]Přemysl Frič, Aleksi Šedo, Jan Škrha, et al.
Nutrition & Diabetes|April 27, 2018
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentationAnna Cinkajzlová, Miloš Mráz, Zdeňka Lacinová, et al.
Annals of Medicine|July 2, 2026
Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal functionBarbora Agatha Halouzková, Michaela Jelínková, Jan Miroslav Hartinger, et al.
European Journal of Gastroenterology & Hepatology|October 22, 2016
Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkersPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Infectious Disease Reports|February 23, 2024
A Simple Risk Formula for the Prediction of COVID-19 Hospital MortalityJiří Plášek, Jozef Dodulík, Petr Gai, et al.
Cardiovascular Diabetology|October 24, 2020
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetesGuntram Schernthaner, Naim Shehadeh, Alexander S Ametov, et al.
European Journal of Internal Medicine|November 9, 2025
Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM's Diabesity Day Survey 2024Ann-Kristin Porth, Anete Palma, Burcu Sallarel, et al.
Pageof 5